MAP2K7 and neoplasm: RAS mutation results in the activation of the RAS/RAF/MEK pathway, so we investigated whether inhibitors of the RAS/RAF/MEK pathway affect the oncolytic efficiency and gene expression of M1 virus in tumor cells.